Aloia Mark S, Arnedt J Todd, Stanchina Michael, Millman Richard P
Department of Medicine, National Jewish Medical and Research Center, Room A109b, 1400 Jackson St.,Denver, CO 80206, USA.
Behav Sleep Med. 2007;5(3):229-40. doi: 10.1080/15402000701264005.
Obstructive sleep apnea (OSA) is a serious disorder with significant daytime consequences. Treatment for OSA most commonly takes the form of positive airway pressure (PAP). Although effective, PAP adherence is often below expectations. Previous studies have suggested that early PAP use can predict long-term adherence, but these studies have not been replicated, nor has follow up been longer than 3 months. This article presents a replication study enhanced by a longer follow up and additional data to suggest that 6-month adherence can be predicted within the first days of PAP use. This article also discusses how this might relate to the experience of significant side effects of treatment.
阻塞性睡眠呼吸暂停(OSA)是一种严重的疾病,会对白天产生重大影响。OSA的治疗最常见的形式是持续气道正压通气(PAP)。尽管PAP有效,但患者的依从性往往低于预期。先前的研究表明,早期使用PAP可以预测长期依从性,但这些研究尚未得到重复验证,且随访时间也未超过3个月。本文通过更长时间的随访和额外的数据进行了一项重复研究,结果表明在使用PAP的头几天内就可以预测6个月的依从性。本文还讨论了这可能与治疗的显著副作用体验之间的关系。